| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $516.4M | +5.3% |
| Cost of Revenue | $120.4M | +62.5% |
| Gross Profit | $396.0M | -4.9% |
| R&D Expense | $265.7M | +25.5% |
| SG&A Expense | $298.3M | +15.8% |
| Operating Income | -$167.9M | -221.4% |
| Interest Expense | $476K | -45.0% |
| Pre-tax Income | -$162.0M | -201.5% |
| Income Tax | $4.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $219.7M | -62.6% |
| Accounts Receivable | $104.2M | +22.2% |
| Inventory | $81.6M | +36.1% |
| Current Assets | $635.0M | -15.1% |
| Total Assets | $1.03B | +1.0% |
| Current Liabilities | $131.0M | +18.7% |
| Total Liabilities | $223.2M | +10.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.6M | -57.2% |
| Capital Expenditures | $131.7M | +30.0% |
| Investing Cash Flow | -$350.9M | -228.8% |
| Financing Cash Flow | $15.8M | -55.2% |
| Free Cash Flow | -$165.3M | -34.7% |
| -10.6% |
| Net Income | -$166.0M | -185.1% |
| EPS (Basic) | -$1.46 | -175.5% |
| EPS (Diluted) | -$1.46 | -175.5% |
| Stockholders' Equity |
| $805.7M |
| -1.4% |